Beta Bionics, Inc. (NASDAQ:BBNX)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $119.0M
- Net income
- -$73.0M
- Net margin
- -61.3%
Little or no net debt.
- Total debt
- $6.5M
- Cash
- $44.3M
- Debt / equity
- 0.03
Comfortably covers what is due within a year.
- Current assets
- $231.0M
- Current liabilities
- $26.0M
- Current ratio
- 8.88
Consumes cash and must keep raising it.
- Operating cash flow
- -$55.8M
- Free cash flow
- -$61.4M
- FCF margin
- -51.6%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 44.5M
- Share growth (1y)
- 2.7%
- Cash runway
- 10 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BBNX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 32.01 M | 27.63 M | 32.12 M | 27.25 M | 23.24 M | 17.64 M |
| Revenue Growth (YoY) | 37.76 % | 56.62 % | 57.15 % | 63.14 % | 54.45 % | 36.39 % |
| Cost of Revenue | 13.11 M | 11.19 M | 13.18 M | 12.13 M | 10.73 M | 8.67 M |
| Gross Profit | 18.90 M | 16.44 M | 18.94 M | 15.12 M | 12.50 M | 8.97 M |
| SG&A Expense | 34.24 M | 30.35 M | 24.94 M | 23.97 M | 23.50 M | 20.02 M |
| R&D Expense | 10.24 M | 10.36 M | 10.13 M | 8.20 M | 8.87 M | 7.59 M |
| Operating Expenses | 44.48 M | 40.71 M | 35.07 M | 32.16 M | 32.38 M | 27.61 M |
| Operating Income | -25.58 M | -24.27 M | -16.12 M | -17.04 M | -19.87 M | -18.64 M |
| Pretax Income | -23.40 M | -21.89 M | -13.47 M | -14.21 M | -16.87 M | -28.66 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -23.40 M | -21.89 M | -13.47 M | -14.21 M | -16.87 M | -28.66 M |
| EPS (Basic) | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 |
| EPS (Diluted) | -0.53 | -0.49 | -0.33 | -0.33 | -0.39 | -0.66 |
| Shares Outstanding | 44.55 M | 44.44 M | 40.53 M | 43.63 M | 43.39 M | 43.12 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.